Publication at Faculty of Medicine in Hradec Králové |
2011
Abstract
We describe our experience with plasma exchange (PE) and immunoadsorption in patients with myasthenia gravis. The group of 27 patients consists of 21 patients treated with PE and 6 patients who received immunoadsorption.
PE therapy led to stabilization in 20 patients. In patients treated with immunoadsorption, therapy could be discontinued in 2 patients after 13 months of therapy, and the other 4 patients were stabilized without myasthenic crises after 6-9 years of therapy.
Extracorporeal elimination therapy through PE or immunoadsorption is effective and sometimes life saving and its safe in the hands of an experimental team (6% complication rate).